Tarloxotinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tarloxotinib, covering 2023-06-28 to 2023-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions [Phase 2]